Full Professor(heuristic)

Cancer Cells and Metastasis · Oncology

h-index55
i10-index115
Publications554
Citations13,961

Grants

36 total · 4 active

NIH #2P30CA125123-19

Patient-Derived Xenograft Shared Resource

Active
Amount
$NaNK
Period
2007-07-01 → 2030-06-30
PIs
1
Est. capacity / PI
~ students

NIH #5U54CA224076-07

PDX Trial Center for Breast Cancer Therapy

Active
Amount
$NaNK
Period
2017-09-25 → 2028-06-30
PIs
3
Est. capacity / PI
~ students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #5U54CA224076-06

Research Project 1: Enhancing neoadjuvant therapy to prevent breast cancer recurrence

Active
Amount
$NaNK
Period
2017-09-25 → 2028-06-30
PIs
1
Est. capacity / PI
~ students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

36 total · 4 active

NIH #2P30CA125123-19

Patient-Derived Xenograft Shared Resource

Active
Amount
$NaNK
Period
2007-07-01 → 2030-06-30
PIs
1
Est. capacity / PI
~ students

NIH #5U54CA224076-07

PDX Trial Center for Breast Cancer Therapy

Active
Amount
$NaNK
Period
2017-09-25 → 2028-06-30
PIs
3
Est. capacity / PI
~ students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #5U54CA224076-06

Research Project 1: Enhancing neoadjuvant therapy to prevent breast cancer recurrence

Active
Amount
$NaNK
Period
2017-09-25 → 2028-06-30
PIs
1
Est. capacity / PI
~ students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #2U54CA224076-05

PDX Trial Center for Breast Cancer Therapy

Active
Amount
$NaNK
Period
2017-09-25 → 2028-06-30
PIs
3
Est. capacity / PI
~ students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #5U24CA226110-05

INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER

Amount
$NaNK
Period
2019-09-19 → 2025-08-31
PIs
3
Est. capacity / PI
~ students

NIH #5P30CA125123-18

Advanced in Vivo Cancer Models

Amount
$NaNK
Period
2007-07-01 → 2025-06-30
PIs
1
Est. capacity / PI
~ students

NIH #5P30CA125123-17

Advanced in Vivo Cancer Models

Amount
$NaNK
Period
2007-07-01 → 2025-06-30
PIs
1
Est. capacity / PI
~ students

NIH #5P30CA125123-16

Advanced in Vivo Cancer Models

Amount
$NaNK
Period
2007-07-01 → 2025-06-30
PIs
1
Est. capacity / PI
~ students

NIH #5P30CA125123-15

Advanced in Vivo Cancer Models

Amount
$NaNK
Period
2007-07-01 → 2025-06-30
PIs
1
Est. capacity / PI
~ students

NIH #2P30CA125123-14

Advanced in Vivo Cancer Models

Amount
$NaNK
Period
2007-07-01 → 2025-06-30
PIs
1
Est. capacity / PI
~ students

NIH #5R01CA224867-05

Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis

Amount
$NaNK
Period
2018-12-01 → 2024-11-30
PIs
2
Est. capacity / PI
~ students

Awarded at UNIVERSITY OF COLORADO DENVER

NIH #5U24CA226110-04

INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER

Amount
$NaNK
Period
2019-09-19 → 2024-08-31
PIs
3
Est. capacity / PI
~ students

NIH #5U24CA226110-03

INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER

Amount
$NaNK
Period
2019-09-19 → 2024-08-31
PIs
3
Est. capacity / PI
~ students

NIH #5U24CA226110-02

INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER

Amount
$NaNK
Period
2019-09-19 → 2024-08-31
PIs
3
Est. capacity / PI
~ students

NIH #1U24CA226110-01A1

INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER

Amount
$NaNK
Period
2019-09-19 → 2024-08-31
PIs
3
Est. capacity / PI
~ students

NIH #5R01CA224867-04

Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis

Amount
$NaNK
Period
2018-12-01 → 2023-11-30
PIs
2
Est. capacity / PI
~ students

Awarded at UNIVERSITY OF COLORADO DENVER

NIH #5R01CA224867-03

Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis

Amount
$NaNK
Period
2018-12-01 → 2023-11-30
PIs
2
Est. capacity / PI
~ students

Awarded at UNIVERSITY OF COLORADO DENVER

NIH #5R01CA224867-02

Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis

Amount
$NaNK
Period
2018-12-01 → 2023-11-30
PIs
2
Est. capacity / PI
~ students

Awarded at UNIVERSITY OF COLORADO DENVER

NIH #1R01CA224867-01A1

Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis

Amount
$NaNK
Period
2018-12-01 → 2023-11-30
PIs
2
Est. capacity / PI
~ students

Awarded at UNIVERSITY OF COLORADO DENVER

NIH #3U54CA224076-04S3

Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance

Amount
$NaNK
Period
2017-09-25 → 2023-06-30
PIs
1
Est. capacity / PI
~ students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #3U54CA224076-04S1

Core-001

Amount
$NaNK
Period
2022-09-01 → 2023-06-30
PIs
2
Est. capacity / PI
~ students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #3U54CA224076-04S2

Core-001

Amount
$NaNK
Period
2022-09-01 → 2023-06-30
PIs
3
Est. capacity / PI
~ students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #5U54CA224076-04

PDX Trial Center for Breast Cancer Therapy

Amount
$NaNK
Period
2017-09-25 → 2023-06-30
PIs
3
Est. capacity / PI
~ students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #6U01CA214172-06

A unique approach combining avatar mice and targeted mass spectrometry to identify blood biomarkers for early detection of breast cancer

Amount
$NaNK
Period
2016-09-19 → 2023-03-31
PIs
2
Est. capacity / PI
~ students

Awarded at FRED HUTCHINSON CANCER CENTER

NIH #3U54CA224076-03S3

Multi-omic, Exposure-informed, Genealogical Approach (mErGE)

Amount
$NaNK
Period
2017-09-25 → 2022-08-31
PIs
3
Est. capacity / PI
~ students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #3U54CA224076-03S1

PDX Trial Center for Breast Cancer Therapy

Amount
$NaNK
Period
2017-09-25 → 2022-08-31
PIs
2
Est. capacity / PI
~ students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #5U54CA224076-03

PDX Trial Center for Breast Cancer Therapy

Amount
$NaNK
Period
2017-09-25 → 2022-08-31
PIs
3
Est. capacity / PI
~ students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #3U54CA224076-03S2

PDX Trial Center for Breast Cancer Therapy

Amount
$NaNK
Period
2017-09-25 → 2022-08-31
PIs
3
Est. capacity / PI
~ students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #3U01CA214172-05S1

A unique approach combining avatar mice and targeted mass spectrometry to identify blood biomarkers for early detection of breast cancer

Amount
$NaNK
Period
2016-09-19 → 2022-03-31
PIs
2
Est. capacity / PI
~ students

Awarded at FRED HUTCHINSON CANCER RESEARCH CENTER

NIH #5U01CA214172-05

A unique approach combining avatar mice and targeted mass spectrometry to identify blood biomarkers for early detection of breast cancer

Amount
$NaNK
Period
2016-09-19 → 2022-03-31
PIs
2
Est. capacity / PI
~ students

Awarded at FRED HUTCHINSON CANCER RESEARCH CENTER

NIH #5U01CA214172-04

A unique approach combining avatar mice and targeted mass spectrometry to identify blood biomarkers for early detection of breast cancer

Amount
$NaNK
Period
2016-09-19 → 2021-08-31
PIs
2
Est. capacity / PI
~ students

Awarded at FRED HUTCHINSON CANCER RESEARCH CENTER

NIH #3R01CA224867-01A1S1

Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis

Amount
$NaNK
Period
2019-08-01 → 2020-11-30
PIs
2
Est. capacity / PI
~ students

Awarded at UNIVERSITY OF COLORADO DENVER

NIH #3U54CA224076-01S1

PDX Trial Center for Breast Cancer Therapy

Amount
$NaNK
Period
2017-09-25 → 2019-08-31
PIs
3
Est. capacity / PI
~ students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #3U54CA224076-01S2

PDX Trial Center for Breast Cancer Therapy

Amount
$NaNK
Period
2017-09-25 → 2019-08-31
PIs
3
Est. capacity / PI
~ students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #4U54CA224076-02

Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance

Amount
$NaNK
Period
— → —
PIs
1
Est. capacity / PI
~ students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #3U54CA224076-02S1

Research Project 2: Targetin Tumor-Initiating Cell (TIC) Heterogeneity To Overcome Chemotherapy Resistance

Amount
$NaNK
Period
— → —
PIs
1
Est. capacity / PI
~ students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 106
Open author page on OpenAlex →